You searched for "medicines"
Latest NHS plan to modernise primary care misses an opportunity
Government announces drive to digitise GP phonelines and offer greater options in patient access to care in dentistry and pharmacy, but does not capitalise on opportunities to improve patient experiences closer to home or address IT connectivity issues holding back optometry services.insitro and UK’s INSIGHT at Moorfields Eye Hospital announce collaboration to expand research efforts in neurodegeneration and related conditions
The world’s largest bioresource of eye images offers window into human health and serves as basis of a new AI foundation model to boost drug discovery. insitro, a machine learning-enabled drug discovery and development company, and the INSIGHT Health Data...Refractionist’s shoulder?
1 June 2015
| Andrew Turnbull
|
EYE - General
After hearing the letter-box, I walked to the front door and stooped down to collect my latest edition of Eye News. I winced. Still, at least it would give me something to pass the time on this, my first day...
Brexit, for richer, for poorer: prospects for post-withdrawal Britain
1 July 2017
| Rod McNeil
|
EYE - General
The people of the United Kingdom voted by 52% to 48% to leave the European Union (EU) in June 2016, a referendum decision intended by a slim majority to restore national self-determination and achieve what many believed to be a...
Results of four years of implantation of XEN glaucoma gel stent
2 December 2019
| Ivan Yip
|
EYE - Glaucoma
|
MIGS, XEN glaucoma gel microstent, efficacy, long-term, safety
This multi-centred prospective, non-randomised study presents the long-term clinical outcomes in patients after implantation of transscleral XEN Glaucoma Gel Microstent, 63μm. (XEN-GGM, Allergan, New Jersey). It was conducted in Austria, Canada and Germany. Sixty-four consecutive eyes of 64 patients with...
Vabysmo receives NICE approval
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...Saving sight and changing lives: working with Syrian refugees in Jordan
Two ophthalmologists from the Emory Eye Center share their three-year experience of treating refugees in the camps in Jordan. Jordan currently hosts an estimated 1.4 million Syrian people who have fled the war in their home country. Cataract & Cornea...Pharmacopoeia of the Royal Infirmary of Edinburgh
4 February 2021
| Andrew King
|
EYE - General
The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....
Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital
The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...Cyanoacrylate nail glue accidentally instilled into the eye instead of eye drops
1 April 2016
| Ajai Murthy, Gwyn Samuel Williams, Hugh Jewsbury, Ayad Al-bermani
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Strabismus, EYE - Refractive, EYE - Vitreo-Retinal
Three hundred thousand cataract operations take place each year in the UK alone and each patient will receive a four week course of drops in order to cover them for any postoperative inflammation or infection. Accidental instillation of cyanoacrylate glue...
Blind Faith: In Conversation with Mariya Moosajee
16 August 2023
|
EYE - General
In light of the BBC releasing Blind Faith: Do genetic eye disease ‘treatments' work? earlier this year, a documentary which follows BBC journalist Ramadan Younes as he investigates practitioners who falsely claim to have ‘treatments’ for genetic eye disease, Eye...
Contemporary glaucoma therapy: spoilt for choice
1 April 2014
| Rod McNeil
|
EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...
